CRCA vs. STPZ
CRCA (ProShares Ultra CRCL) and STPZ (PIMCO 1-5 Year US TIPS Index ETF) are both exchange-traded funds - CRCA is a Leveraged Equities fund actively managed by ProShares, while STPZ is a Inflation-Protected Bonds fund tracking the ICE BofA US Inflation-Linked Treasury (1-5 Y). CRCA is actively managed, while STPZ is passively managed. At a correlation of -0.00, they often move in opposite directions. CRCA charges 0.95%/yr vs 0.20%/yr for STPZ.
Performance
CRCA vs. STPZ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -25.12% return, which is significantly lower than STPZ's 1.77% return.
CRCA
- 1D
- 0.33%
- 1M
- -42.95%
- YTD
- -25.12%
- 6M
- -41.42%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
STPZ
- 1D
- -0.01%
- 1M
- 0.03%
- YTD
- 1.77%
- 6M
- 1.77%
- 1Y
- 4.41%
- 3Y*
- 4.99%
- 5Y*
- 2.90%
- 10Y*
- 2.88%
CRCA vs. STPZ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -25.12% | -81.81% |
STPZ PIMCO 1-5 Year US TIPS Index ETF | 1.77% | 1.02% |
Correlation
The correlation between CRCA and STPZ is -0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Aug 8, 2025 | -0.00 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. STPZ — Risk / Return Rank
CRCA
STPZ
CRCA vs. STPZ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and PIMCO 1-5 Year US TIPS Index ETF (STPZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| CRCA | STPZ | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 2.43 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.89 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.97 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.47 | 0.90 | -1.37 |
Drawdowns
CRCA vs. STPZ - Drawdown Comparison
The maximum CRCA drawdown since its inception was -94.02%, which is greater than STPZ's maximum drawdown of -6.77%. Use the drawdown chart below to compare losses from any high point for CRCA and STPZ.
Loading charts...
Drawdown Indicators
| CRCA | STPZ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.02% | -6.77% | -87.25% |
Max Drawdown (1Y)Largest decline over 1 year | — | -0.93% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -1.35% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -6.70% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -6.77% | — |
Current DrawdownCurrent decline from peak | -87.94% | -0.13% | -87.81% |
Average DrawdownAverage peak-to-trough decline | -69.35% | -1.31% | -68.04% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 0.28% | — |
Volatility
CRCA vs. STPZ - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | STPZ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 0.44% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 1.20% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 196.32% | 1.82% | +194.50% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 196.32% | 3.29% | +193.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 196.32% | 2.98% | +193.34% |
CRCA vs. STPZ - Expense Ratio Comparison
CRCA has a 0.95% expense ratio, which is higher than STPZ's 0.20% expense ratio.
Dividends
CRCA vs. STPZ - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 2.31%, less than STPZ's 4.11% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRCA ProShares Ultra CRCL | 2.31% | 1.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
STPZ PIMCO 1-5 Year US TIPS Index ETF | 4.11% | 3.65% | 1.97% | 1.63% | 5.88% | 3.65% | 1.86% | 1.76% | 2.23% | 1.51% | 0.65% | 0.49% |
Frequently Asked Questions
CRCA and STPZ have a correlation of -0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, STPZ is cheaper at 0.20% per year. The better choice depends on whether you care most about return, fees, risk, or income.
STPZ is cheaper with a 0.20% expense ratio, compared with 0.95% for CRCA.
STPZ has the higher dividend yield at 4.11%, compared with 2.31% for CRCA.
CRCA is categorized as Leveraged Equities, while STPZ is Inflation-Protected Bonds. They also come from different issuers: ProShares and PIMCO. Their fees differ too: 0.95% for CRCA and 0.20% for STPZ.
Find the right allocation for CRCA and STPZ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer